(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Botulinum neurotoxins exert an analgesic effect through a variety of mechanisms including inhibition of acetylcholine…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Spasticity is a common and disabling complication of stroke, multiple sclerosis, brain and spinal cord…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Chronic low back pain is a common condition with diverse etiologies. It is a major…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Chronic facial pain is physically and emotionally disabling. Trigeminal neuralgia, pain associated with temporomandibular disorders,…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Neuropathic pain (NP) is a common form of human pain, often poorly responsive to analgesic…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract The availability of novel technologies has been crucial in the discovery and description of new…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Primary headaches consist of migraine, tension-type headaches, and trigeminal autonomic cephalalgias (e.g., cluster headache). Migraine…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Postsurgical pain is a common disorder which results from spasm of muscles or sphincters and…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract High-quality data regarding the efficacy of botulinum neurotoxins (BoNTs) in pelvic and urogenital pain disorders…
(1) Botulinum Toxin Treatment Program, Yale School of Medicine, New Haven, CT, USA Abstract Plantar fasciitis/fasciopathy (PF) is a common problem which affects two million people in the USA…
